CDK4 and breast carcinoma: Comprehensively taking into account the function of YB-1 phosphorylation in promoting DSB repair and driving the cell cycle G1/S phase transition, we hypothesized that YB-1 phosphorylation may remove the blocking effect of CDK4/6i on the G1/S phase transition and lead to the occurrence of CDK4/6i resistance in breast cancer.